ADHD tests for private healthcare sector

QbTest and QbCheck help private healthcare services standardize ADHD care, address regulatory concerns, and assess flexibly— our solutions scale with your growth, providing options to test your patients in-clinic or remotely.

Standardize ADHD care with clinically validated tools 

Get started with reliable and clinically validated ADHD diagnosis and treatment monitoring tools to maintain high levels of care and standardization.

The National Institute for Health and Care Excellence (NICE) published in MIB318 in Europe, that QbTest saves clinician time and NHS money when used as part of ADHD evaluations – with no loss of accuracy.

This reliability is crucial for private practitioners who need to ensure that your services meet regulatory requirements and patient expectations.

Flexible integration and support, including remote testing 

There isn’t a “one-size fits all” approach to ADHD care and management. We work with you to incorporate our technology into your pathways with pricing models to align best with your clinical and commercial needs.

Offering both in-clinic and remote ADHD testing options as well as high volume test plans and other flexible options, you can use our technology as part of your needs and reach a higher number of patients.

Expert training and support from the get-go with our expert clinical advisors ensure smooth integration and ongoing success.

Use objective testing for treatment review and management 

Our tests offer detailed insights into patient symptoms and progress over any length of time.

Used alongside other clinical measures, you have the insight to develop tailored treatment plans for your patients and monitor their effectiveness over time, ensuring everyone gets personalized and effective care.

Our technology captures 86% of patient’s treatment effects. The AQUA study found that QbTest can distinguish pharmacological treatment effects within hours of medication and can be used for optimization and monitoring of long-term treatment of ADHD.

Get access to healthcare marketing support 

We provide private practices support with marketing services which use our ADHD testing technology. We can help you to build a trusted reputation for clinical excellence with a tool that helps you streamline your pathway and work more efficiently.

The AQUA study found QbTest reduced the time to diagnostic decision by 44% and clinicians were 77% more likely to be confident in diagnosing or ruling out ADHD.

Addressing stakeholder concerns 

Following recent media scrutiny, private services are under more pressure than ever to meet high standards of ADHD care. Our technology can help you demonstrate high quality care and outcomes to payors and policy makers.